CAS: 138530-95-7 - (S)-Lansoprazole

Formel: C₁₆H₁₄F₃N₃O₂S

InChl: InChI=1/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m0/s1

Synonyme:

• 1H-Benzimidazole, 2-[(S)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]- (9CI)
• 1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-, (S)-
• Levolansoprazole
• 2-[(S)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
• 2-[(S)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl]-1H-benzimidazole

1H-Benzimidazole, 2-[(S)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-

CAS: 138530-95-7

• Formel: C₁₆H₁₄F₃N₃O₂S
• Reinheit: 99%
• Farbe und Form: Solid
• Molekulargewicht: 369.3615

(S)-Lansoprazole

CAS: 138530-95-7

• Formel: C₁₆H₁₄F₃N₃O₂S
• Farbe und Form: Off-White Solid
• Molekulargewicht: 369.36

Levolansoprazole

CAS: 138530-95-7

Levolansoprazole ((S)-Lansoprazole), a proton pump inhibitor, irreversibly inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50: …

• Formel: C₁₆H₁₄F₃N₃O₂S
• Reinheit: 98.62%
• Farbe und Form: Solid
• Molekulargewicht: 369.36

(S)-Lansoprazole

CAS: 138530-95-7

Gastric proton pump inhibitor

• Formel: C₁₆H₁₄F₃N₃O₂S
• Reinheit: Min. 95%
• Farbe und Form: White Powder
• Molekulargewicht: 369.36 g/mol

(S)-Lansoprazole

CAS: 138530-95-7

Applications The S-enantiomer of Lansoprazole; a gastric proton pump inhibitor. An antiulcerative. References Figgitt, D., …

• Formel: C₁₆H₁₄F₃N₃O₂S
• Farbe und Form: Neat
• Molekulargewicht: 369.36